Community-Based Engagement to Improve Lung Cancer Screening and Outcomes: The "Our Lungs Our Health" Study

Community-Based Engagement to Improve Lung Cancer Screening and Outcomes

The main goal of this pilot study is to understand the impact of a mobile lung cancer screening clinics in individuals from neighborhoods and communities with less access to resources in Boston, Massachusetts who are at high risk for lung cancer. A secondary goal of this pilot study is to understand how social determinants of health impact these neighborhoods and communities. Another secondary goal of this pilot study is to see if video recording of participants speaking to their future selves and sending the videos back to participants to encourage them to get lung cancer screening after one year can be administered in a mobile lung cancer screening setting. The questions this study aims to answer are:

• Is mobile lung cancer screening is feasible and acceptable?
• Is collecting social needs data during the mobile lung cancer screening clinics feasible?
• Is creating video recordings of patients encouraging their future selves to get lung cancer screening after one year feasible?

Participants will:

• Complete an intake survey, providing information about their demographic, medical, and social needs information.
• Undergo a shared decision-making conversation to determine whether lung cancer screening should be done.
• Undergo lung cancer screening.
• Undergo a debriefing conversation and fill out an acceptability survey.
• Record a video speaking to their future selves about the importance of annual lung cancer screening, with the video to be sent back to them after roughly one year.
• Undergo a semi-structured phone interview between four and eight weeks after lung cancer screening date.

Study Overview

• Status: Not yet recruiting
• Conditions: Lung Cancer Screening
• Intervention / Treatment: Radiation: Low-Dose Computed Tomography Scan

• Study Type: Interventional
• Enrollment (Estimated): 125
• Phase: Not Applicable

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: Adult; Older Adult
• Accepts Healthy Volunteers: Yes

Description

Inclusion Criteria:

• Ability to understand and the willingness to sign a written informed consent document prior to any study-related procedures.
• Willing to undergo treatment.
• Adults between the ages of 50 and 80 years.
• No recent CT imaging within the last year.
• Currently smokes tobacco or has quit smoking tobacco within the past 15 years.
• Has a tobacco smoking history of at least 20 pack years (i.e. one pack per day for the last 20 years or equivalent).
• Has never been diagnosed with lung cancer.

Exclusion Criteria:

• Adults/children less than 50 years, or greater than 80 years of age.
• Has never smoked tobacco.
• Has smoked tobacco but quit more than 15 years ago.
• Has a tobacco smoking history of less than 20 pack years.
• Presence of major comorbidity(ies) that could prevent treatment.
• Previous diagnosis of lung cancer.
• In the opinion of the investigator, the subject is not an appropriate candidate for the study.

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Screening
• Allocation: N/A
• Interventional Model: Single Group Assignment
• Masking: None (Open Label)

Number of Arms

1

Arms and Interventions

Participant Group / Arm

Intervention / Treatment

Experimental: Lung Cancer Screening; Participants will complete a baseline questionnaire and undergo a shared decision-making with the study team to determine whether they will receive lung cancer screening. If the participant and team member determine that lung cancer screening should be performed, they will undergo screening. Regardless of whether lung cancer screening is performed, participants will undergo a debriefing conversation. An acceptability survey will be given to participants who underwent lung cancer screening. Those who undergo lung cancer screening will also be video-recorded speaking to their future selves as encouragement to get annual lung cancer screening. Imaging results will be returned to the participant and their care team within two weeks after lung cancer screening. Semi-structured interviews will also be performed with participants who underwent lung cancer screening between four and eight weeks after lung cancer screening. Video footage will be returned to patients after 48 weeks.

Radiation: Low-Dose Computed Tomography Scan; Imaging of chest to screen for lung cancer.; Other Names: CAT Scan; CT Scan; LDCT Scan

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Feasibility of mobile lung cancer screening in target communities in Boston, Massachusetts.	This outcome will be assessed by calculating the raw count of individuals screened at each mobile clinic and the number of individuals unable to be screened due to time constraints.	During the intervention.
Acceptability of mobile lung cancer screening in target communities in Boston, Massachusetts.	Acceptability will be assessed using semi-structured phone interviews with participants. Responses to questions, themes, and keywords will be analyzed to report attitudes regarding the intervention.	Between four and eight weeks after the intervention

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Feasibility of collecting social determinants of health data during mobile lung cancer screening clinics in underserved communities in Boston, Massachusetts.	Feasibility will be measured using the raw count of completed intake surveys.	Pre-intervention
Feasibility of administering a video-based intervention to encourage annual lung cancer screening	Participants who undergo mobile lung cancer screening will be recorded speaking to their future selves about the importance of annual lung cancer screening. The video footage will be returned to participants 48 weeks after mobile lung cancer screening to encourage the patient to schedule their next screening.	From enrollment until the end of the study.

Collaborators and Investigators

• Sponsor: Brigham and Women's Hospital

Study record dates

Study Major Dates

• Study Start (Estimated): May 1, 2026
• Primary Completion (Estimated): November 1, 2026
• Study Completion (Estimated): November 1, 2026

Study Registration Dates

• First Submitted: March 21, 2025
• First Submitted That Met QC Criteria: March 27, 2025
• First Posted (Actual): April 4, 2025

Study Record Updates

• Last Update Posted (Actual): December 8, 2025
• Last Update Submitted That Met QC Criteria: December 2, 2025
• Last Verified: December 1, 2025

More Information

Terms related to this study

• Keywords: Lung Cancer Screening
• Additional Relevant MeSH Terms: Neoplasms by Site; Neoplasms; Respiratory Tract Diseases; Lung Diseases; Respiratory Tract Neoplasms; Thoracic Neoplasms; Lung Neoplasms
• Other Study ID Numbers: 24-715

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No
• product manufactured in and exported from the U.S.: No